I. Adamová

729 total citations
41 papers, 538 citations indexed

About

I. Adamová is a scholar working on Surgery, Molecular Biology and Immunology. According to data from OpenAlex, I. Adamová has authored 41 papers receiving a total of 538 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Surgery, 10 papers in Molecular Biology and 10 papers in Immunology. Recurrent topics in I. Adamová's work include Lipoproteins and Cardiovascular Health (19 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Cancer, Lipids, and Metabolism (8 papers). I. Adamová is often cited by papers focused on Lipoproteins and Cardiovascular Health (19 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Cancer, Lipids, and Metabolism (8 papers). I. Adamová collaborates with scholars based in Russia, United States and Germany. I. Adamová's co-authors include S. Pokrovsky, O. Afanasieva, Vladimir N. Smirnov, Alexander N. Orekhov, М. В. Ежов, V.V. Tertov, Maya Safarova, G A Konovalov, A. A. Lyakishev and Alexander E. Kabakov and has published in prestigious journals such as SHILAP Revista de lepidopterología, Circulation Research and Atherosclerosis.

In The Last Decade

I. Adamová

39 papers receiving 505 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
I. Adamová Russia 12 316 184 124 97 89 41 538
Pnina Keren Israel 10 65 0.2× 240 1.3× 39 0.3× 150 1.5× 22 0.2× 16 455
Nadia Kourda Tunisia 16 170 0.5× 134 0.7× 21 0.2× 188 1.9× 130 1.5× 60 699
Andrzej Gabriel Poland 16 106 0.3× 56 0.3× 49 0.4× 142 1.5× 50 0.6× 45 530
Selja Koskensalo Finland 14 212 0.7× 59 0.3× 82 0.7× 281 2.9× 182 2.0× 28 699
Wei Xue China 15 49 0.2× 169 0.9× 25 0.2× 207 2.1× 46 0.5× 59 559
Marsel Lino Canada 13 73 0.2× 52 0.3× 58 0.5× 140 1.4× 68 0.8× 17 396
Mahsa Molaei Iran 18 339 1.1× 101 0.5× 21 0.2× 170 1.8× 35 0.4× 51 762
Yoshinori Doki Japan 12 117 0.4× 66 0.4× 21 0.2× 179 1.8× 88 1.0× 40 544
Felix Zhou United States 8 67 0.2× 127 0.7× 52 0.4× 451 4.6× 119 1.3× 24 652
Debra L. Robson Canada 8 88 0.3× 102 0.6× 24 0.2× 180 1.9× 47 0.5× 9 619

Countries citing papers authored by I. Adamová

Since Specialization
Citations

This map shows the geographic impact of I. Adamová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. Adamová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. Adamová more than expected).

Fields of papers citing papers by I. Adamová

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I. Adamová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. Adamová. The network helps show where I. Adamová may publish in the future.

Co-authorship network of co-authors of I. Adamová

This figure shows the co-authorship network connecting the top 25 collaborators of I. Adamová. A scholar is included among the top collaborators of I. Adamová based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I. Adamová. I. Adamová is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Левашов, П. А., et al.. (2019). New Sorbent on the Basis of Covalently Immobilized Lysozyme for Removal of Bacterial Lipopolysaccharide (Endotoxin) from Biological Fluids. Biochemistry (Moscow). 84(1). 33–39. 9 indexed citations
3.
Левашов, П. А., et al.. (2019). A Novel Method of Covalent Lysozyme Immobilization for the Development of Materials for Medical Applications. Russian Journal of Bioorganic Chemistry. 45(2). 101–106. 8 indexed citations
4.
Ежов, М. В., O. Afanasieva, Larisa Ilina, et al.. (2017). Association of lipoprotein(a) level with short- and long-term outcomes after CABG: The role of lipoprotein apheresis. Atherosclerosis Supplements. 30. 187–192. 18 indexed citations
5.
Adamová, I., et al.. (2017). FIRST CLINICAL EXPERIENCE OF USING COLUMN FOR LPS-ADSORPTION OF TOXIPAK IN TREATMENT OF SEPSIS PATIENTs. Messenger of Anesthesiology and Resuscitation. 14(5). 42–50. 7 indexed citations
6.
Pokrovsky, S., O. Afanasieva, Maya Safarova, et al.. (2017). Specific Lp(a) apheresis: A tool to prove lipoprotein(a) atherogenicity. Atherosclerosis Supplements. 30. 166–173. 27 indexed citations
8.
Ежов, М. В., Maya Safarova, O. Afanasieva, et al.. (2015). Specific Lipoprotein(a) apheresis attenuates progression of carotid intima-media thickness in coronary heart disease patients with high lipoprotein(a) levels. Atherosclerosis Supplements. 18. 163–169. 24 indexed citations
9.
Левашов, П. А., et al.. (2015). Affinity hemosorbents based on aromatic peptides for the binding of immunoglobulins G. Russian Journal of Bioorganic Chemistry. 41(5). 494–499. 6 indexed citations
11.
Спиридонова, В. А., et al.. (2014). DNA aptamer-based sorbents for binding human IgE. Russian Journal of Bioorganic Chemistry. 40(2). 151–154. 2 indexed citations
12.
Safarova, Maya, М. В. Ежов, O. Afanasieva, et al.. (2013). Effect of specific lipoprotein(a) apheresis on coronary atherosclerosis regression assessed by quantitative coronary angiography. Atherosclerosis Supplements. 14(1). 93–99. 95 indexed citations
13.
Ежов, М. В., et al.. (2010). Lipoprotein (a) polymorphism as a risk factor of coronary and carotid atherosclerosis and its complications in women. SHILAP Revista de lepidopterología. 2 indexed citations
14.
Левашов, П. А., et al.. (2010). Preparation of affinity sorbents with immobilized synthetic ligands for therapeutic apheresis. Biomeditsinskaya Khimiya. 56(6). 739–746. 1 indexed citations
15.
Pokrovsky, S., et al.. (1996). Lp(a)-APHERESIS : WHAT WE CAN SAY TODAY. 15. 1 indexed citations
16.
Pokrovsky, S., et al.. (1995). Development of Immunosorbents for apoB‐Containing Lipoproteins Apheresis. Artificial Organs. 19(6). 500–505. 16 indexed citations
17.
Pokrovsky, S., et al.. (1994). Extracorporeal immunoadsorption for the specific removal of lipoprotein (a) (Lp(a) apheresis): preliminary clinical data. Chemistry and Physics of Lipids. 67-68. 323–330. 36 indexed citations
18.
Fuki, Ilia V., et al.. (1991). Interaction of apolipoprotein B-containing lipoprotein secreted by Hep G2 cells with receptors for low-density lipoprotein. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 1086(2). 237–240. 3 indexed citations
19.
Pokrovsky, S., I. Adamová, & O. Afanasieva. (1991). Immunosorbent for Selective Removal of Lipoprotein (a) from Human Plasma: In Vitro Study. Artificial Organs. 15(2). 136–140. 33 indexed citations
20.
Pokrovsky, S., et al.. (1990). Immunosorbents for LDL-Apheresis. Biomaterials Artificial Cells and Artificial Organs. 18(5). 623–628. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026